Pharma Aids Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Pharma Aids has a total shareholder equity of BDT339.0M and total debt of BDT3.9M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are BDT456.5M and BDT117.5M respectively. Pharma Aids's EBIT is BDT76.2M making its interest coverage ratio 315.4. It has cash and short-term investments of BDT50.1M.
Anahtar bilgiler
1.1%
Borç/özkaynak oranı
৳3.87m
Borç
| Faiz karşılama oranı | 315.4x |
| Nakit | ৳50.15m |
| Eşitlik | ৳338.96m |
| Toplam yükümlülükler | ৳117.53m |
| Toplam varlıklar | ৳456.50m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: PHARMAID's short term assets (BDT394.7M) exceed its short term liabilities (BDT117.4M).
Uzun Vadeli Yükümlülükler: PHARMAID's short term assets (BDT394.7M) exceed its long term liabilities (BDT141.1K).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: PHARMAID has more cash than its total debt.
Borcun Azaltılması: PHARMAID's debt to equity ratio has reduced from 7.7% to 1.1% over the past 5 years.
Borç Kapsamı: PHARMAID's debt is well covered by operating cash flow (775.6%).
Faiz Kapsamı: PHARMAID's interest payments on its debt are well covered by EBIT (315.4x coverage).